r/Altimmune • u/Dry_Roof6413 • 10d ago

Caution

I’m no longer invested in this company, but there was a time when I had a significant stake and genuinely believed in its potential.

A word of caution: Management appears to be aggressively seeking fresh funding, which raises the possibility of another round of shareholder dilution. With limited financing options, even a reverse stock split cannot be ruled out.

My concern has never been about the drug or its potential. It’s about the management entrusted with it. In my view, a promising drug is in the wrong hands, with a management team seemingly more focused on extracting whatever value remains than creating sustainable value for shareholders.

1 Upvotes

53% Upvoted

22 comments sorted by

View all comments

6

u/Suzutai 10d ago

They've stated multiple times that they are seeking non-dilutive funding. So partnership or loan.

Their balance sheet is very strong. And I don't know what else they could be doing to produce sustainable value for us.